Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Cancer Metastasis Reviews|April 29, 2022
Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantationMatthew J Pianko, Jonathan L GolobLeukemia & Lymphoma|October 29, 2022
Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myelomaAnisa Bici, Matthew J Pianko, Victoria R NacharClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Immunotherapy of Lymphoma and Myeloma: Facts and HopesMatthew J Pianko, Alison J Moskowitz, Alexander M LesokhinStem Cell Investigation|May 23, 2017
Immune checkpoint blockade for hematologic malignancies: a reviewMatthew J Pianko, Yuzhou Liu, Srishti Bagchi, et al.Cancer Journal (Sudbury, Mass.)|January 24, 2018
Clinical Development of PD-1 Blockade in Hematologic MalignanciesMatthew J Pianko, Aaron D Goldberg, Alexander M LesokhinLeukemia & Lymphoma|October 28, 2024
Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practiceMatthew J Pianko, Hira S Mian, Kelly L Schoenbeck, et al.Blood Cancer Journal|May 10, 2023
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort studyHira Mian, Tanya M Wildes, Ravi Vij, et al.The Journal of Applied Laboratory Medicine|October 23, 2019
Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab AssayKatie L Thoren, Matthew J Pianko, Youssef Maakaroun, et al.Cancers|November 14, 2023
Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and SurvivalJonathan D Diedrich, Craig E Cole, Matthew J Pianko, et al.Future Science OA|July 12, 2025
Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myelomaMatthew J Pianko, Niodita Gupta-Werner, Bruno Emond, et al.Pageof 3